Hikal Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Hikal Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹689 of operating cash. Higher than almost all Healthcare companies in India.
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 1 of 3. Less steady than 94% of Healthcare companies in India.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 27% of its market value (net debt). Lower than 94% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹689Over the last 3 years, every ₹100 of reported profit came with ₹689 of operating cash.
Higher than almost all Healthcare companies in India.
Self-Funding Ratio
1.6×Over the last 3 years its own operating cash covered its investment spending (capex) 1.6 times.
Higher than 60% of Healthcare companies in India.
Cash Locked Ratio
₹29For every ₹100 of sales, ₹29 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹20 tied up three years earlier.
More money tied up than 60% of Healthcare companies in India.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 94% of Healthcare companies in India.
Growth Efficiency Ratio
—Sales fell 15%
Sales fell 15% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-15% / -1%In 3 years sales changed by -15% while total assets changed by -1%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
1.0×Debt due within a year is covered 1.0 times by its yearly operating cash.
Lower than 52% of Healthcare companies in India.
Cash Cushion Ratio
−27%Debt, after subtracting cash, equals 27% of its market value (net debt).
Lower than 94% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 72% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 71% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Hikal Limited made a loss over the last year. Hikal Limited owes ₹0.49 for every ₹1 it owns. Hikal Limited made a loss in the year to Mar 2026, after a profit the year before.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
LossHikal Limited made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.09The share price is 2.09 times Hikal Limited's book value per share, lower than 87% of Healthcare companies in India.
Market cap
₹2,505 CrThe total market value of all of Hikal Limited's shares at today's price (share price × number of shares), smaller than 60% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹1,199 CrWhat Hikal Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹97.23Net worth divided by the number of shares. The share price of ₹203.18 is 2.1 times this, which is the P/B above.
Return on equity (ROE)
-2.8%Hikal Limited lost 2.8% of its shareholders' money over the last year, lower than 96% of Healthcare companies in India.
Owes vs Owns
0.49×Hikal Limited owes ₹0.49 for every ₹1 it owns (low), higher than 81% of Healthcare companies in India.
Dividend yield
0.28%Hikal Limited pays 0.28% of its share price as dividends a year, lower than 60% of dividend-paying Healthcare companies in India.
Revenue growth
-8%Revenue fell 8% in the year to Mar 2026, and shrank 5% a year on average over 3 years.
Profit growth
LossHikal Limited made a loss in the year to Mar 2026, after a profit the year before.
Profit margin
-2.9%Hikal Limited lost ₹3 for every ₹100 of revenue.
Interest cover
1.0×Hikal Limited's operating profit covered its interest costs 1.0 times in the year to Mar 2026.
Cash vs debt
Net debtHikal Limited had ₹670 Cr more debt than cash (net debt) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Hikal Limited: ₹2,505 Cr ÷ ₹1,199 Cr (31 Mar 2026) = 2.1.
What is Hikal Limited's return on equity?
Hikal Limited lost 2.8% of its shareholders' money over the last year, lower than 96% of Healthcare companies in India.
How much does Hikal Limited owe compared with what it owns?
Hikal Limited owes ₹0.49 for every ₹1 it owns (low), higher than 81% of Healthcare companies in India.
Does Hikal Limited pay a dividend?
Yes. Hikal Limited pays 0.28% of its share price as dividends a year, lower than 60% of dividend-paying Healthcare companies in India.
Is Hikal Limited's revenue growing?
Revenue fell 8% in the year to Mar 2026, and shrank 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.